Characteristic | Colombia (N = 277) | Brazil (N = 130) | Mexico (N = 83) | Argentina (N = 56) | All Patients Latin America Subregion (N = 546) |
---|---|---|---|---|---|
Past use of osteoporosis medicationa, n (%) | 181 (65.3%) | 96 (73.8%) | 58 (69.9%) | 52 (92.9%) | 387 (70.9%) |
Number of previous osteoporosis medications, n (%) | |||||
0 | 96 (34.7%) | 34 (26.2%) | 25 (30.1%) | 4 (7.1%) | 159 (29.1%) |
1 | 95 (34.3%) | 29 (22.3%) | 12 (14.5%) | 10 (17.9%) | 146 (26.7%) |
2 | 60 (21.7%) | 39 (30.0%) | 14 (16.9%) | 23 (41.1%) | 136 (24.9%) |
3 | 20 (7.2%) | 24 (18.5%) | 11 (13.3%) | 17 (30.4%) | 72 (13.2%) |
4 | 5 (1.8%) | 4 (3.1%) | 17 (20.5%) | 1 (1.8%) | 27 (4.9%) |
5 or more | 1 (0.4%) | 0 (0.0%) | 4 (4.8%) | 1 (1.8%) | 6 (1.1%) |
Previous pharmacotherapy for osteoporosisb, n (%) | |||||
Alendronate | 31 (11.2%) | 37 (28.5%) | 20 (24.1%) | 6 (10.7%) | 94 (17.2%) |
Ibandronate | 23 (8.3%) | 3 (2.3%) | 9 (10.8%) | 11 (19.6%) | 46 (8.4%) |
Risedronate | 4 (1.4%) | 10 (7.7%) | 4 (4.8%) | 6 (10.7%) | 24 (4.4%) |
Zoledronate | 21 (7.6%) | 6 (4.6%) | 23 (27.7%) | 1 (1.8%) | 51 (9.3%) |
Other bisphosphonates | 1 (0.4%) | 1 (0.8%) | 1 (1.2%) | 2 (3.6%) | 5 (0.9%) |
Any one or more bisphosphonates | 73 (26.4%) | 49 (37.7%) | 46 (55.4%) | 22 (39.3%) | 190 (34.8%) |
Calcitonin | 3 (1.1%) | 3 (2.3%) | 1 (1.2%) | 0 (0.0%) | 7 (1.3%) |
Calcium only | 119 (43.0%) | 65 (50.0%) | 34 (41.0%) | 39 (69.6%) | 257 (47.1%) |
Denosumab | 13 (4.7%) | 0 (0.0%) | 8 (9.6%) | 5 (8.9%) | 26 (4.8%) |
Raloxifene | 0 (0.0%) | 1 (0.8%) | 3 (3.6%) | 0 (0.0%) | 4 (0.7%) |
Strontium ranelate | 2 (0.7%) | 4 (3.1%) | 1 (1.2%) | 2 (3.6%) | 9 (1.6%) |
Vitamin D only | 82 (29.6%) | 61 (46.9%) | 31 (37.3%) | 45 (80.4%) | 219 (40.1%) |
Use of ≥1 back pain medication over the past 24 h, n (%) | 94 (33.9%) | 23 (17.7%) | 24 (28.9%) | 26 (46.4%) | 167 (30.6%) |
Specific back pain medications, n (%) | |||||
NSAIDs | 11 (4.0%) | 6 (4.6%) | 19 (22.9%) | 14 (25.0%) | 50 (9.2%) |
Paracetamol | 66 (23.8%) | 5 (3.8%) | 10 (12.0%) | 8 (14.3%) | 89 (16.3%) |
Opioids | 22 (7.9%) | 2 (1.5%) | 0 (0.0%) | 4 (7.1%) | 28 (5.1%) |
Paracetamol and opioid combination | 2 (0.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (0.4%) |